Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Common
-
Shares outstanding
-
49,594,356
-
Total 13F shares
-
7,611,671
-
Share change
-
-675,377
-
Total reported value
-
$30,140,860
-
Put/Call ratio
-
227%
-
Price per share
-
$3.96
-
Number of holders
-
69
-
Value change
-
-$3,801,963
-
Number of buys
-
31
-
Number of sells
-
37
Institutional Holders of PDS Biotechnology Corp - Common (PDSB) as of Q1 2024
As of 31 Mar 2024,
PDS Biotechnology Corp - Common (PDSB) was held by
69 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,611,671 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, INSPIRION WEALTH ADVISORS, LLC, RENAISSANCE TECHNOLOGIES LLC, NORTHERN TRUST CORP, SUSQUEHANNA INTERNATIONAL GROUP, LLP, Sofinnova Investments, Inc., and LPL Financial LLC.
This page lists
69
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.